Bioatla Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Bioatla Stock Summary

Bioatla competes with Pmv Pharmaceuticals, C4 Therapeutics, Nautilus Biotechnology, Century Therapeutics, and Passage Bio. BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California. Bioatla operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 56 people.

Bioatla Key Financial Ratios

Bioatla Key Balance Sheet Accounts

Bioatla Key Income Statement Accounts

Bioatla Key Cash Accounts

Bioatla Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bioatla's current stock value. Our valuation model uses many indicators to compare Bioatla value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioatla competition to find correlations between indicators driving Bioatla's intrinsic value. More Info.Bioatla is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Bioatla's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioatla's earnings, one of the primary drivers of an investment's value.

Bioatla Systematic Risk

Today, most investors in Bioatla Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Bioatla's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Bioatla growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Bioatla help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bioatla. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bioatla based on widely used predictive technical indicators. In general, we focus on analyzing Bioatla Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bioatla's daily price indicators and compare them against related drivers.

When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.